Wealthfront Advisers LLC Regeneron Pharmaceuticals, Inc. Transaction History

Wealthfront Advisers LLC

$32.2 Billion
Q3 2024

A detailed history of Wealthfront Advisers LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealthfront Advisers LLC holds 9,489 shares of REGN stock, worth $6.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

9,489

Previous 9,586 1.01%

Holding current value

$6.8 Million

Previous $10.1 Million 0.99%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1024.09 - $1201.76 $99,336 - $116,570	-97 Reduced 1.01%	9,489 $9.98 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $136,012 - $164,963	-154 Reduced 1.58%	9,586 $10.1 Million
Q1 2024 Apr 19, 2024	BUY	$902.69 - $993.35 $116,447 - $128,142	129 Added 1.34%	9,740 $9.37 Million
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $112,401 - $127,846	145 Added 1.53%	9,611 $8.44 Million
Q3 2023 Nov 01, 2023	SELL	$692.45 - $844.37 $816,398 - $995,512	-1,179 Reduced 11.08%	9,466 $7.79 Million
Q2 2023 Aug 07, 2023	SELL	$700.03 - $830.35 $4.16 Million - $4.93 Million	-5,943 Reduced 35.83%	10,645 $7.65 Million
Q1 2023 Apr 28, 2023	BUY	$680.49 - $826.97 $4.28 Million - $5.2 Million	6,294 Added 61.14%	16,588 $13.6 Million
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $52,941 - $57,479	-75 Reduced 0.72%	10,294 $7.43 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $1 Million - $1.27 Million	1,749 Added 20.29%	10,369 $7.14 Million
Q2 2022 Jul 20, 2022	BUY	$548.35 - $738.84 $2.68 Million - $3.61 Million	4,881 Added 130.54%	8,620 $5.1 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $23,804 - $27,937	40 Added 1.08%	3,739 $2.61 Million
Q4 2021 Jan 21, 2022	BUY	$543.48 - $670.97 $70,652 - $87,226	130 Added 3.64%	3,699 $2.34 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $43,626 - $51,752	76 Added 2.18%	3,569 $2.16 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $1.41 Million - $1.67 Million	-2,990 Reduced 46.12%	3,493 $1.95 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $545,457 - $669,352	-1,221 Reduced 15.85%	6,483 $3.07 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $1.58 Million - $2.01 Million	3,301 Added 74.97%	7,704 $3.72 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $369,340 - $446,266	-678 Reduced 13.34%	4,403 $2.47 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $2.07 Million - $2.71 Million	4,205 Added 480.02%	5,081 $3.17 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $55,469 - $81,580	165 Added 23.21%	876 $428,000
Q4 2019 Jan 21, 2020	BUY	$274.13 - $376.51 $194,906 - $267,698	711 New	711 $267,000
Q3 2019 Oct 15, 2019	SELL	$273.46 - $318.39 $362,061 - $421,548	-1,324 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $49,733 - $68,860	-166 Reduced 11.14%	1,324 $414,000
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $163,343 - $192,971	439 Added 41.77%	1,490 $612,000
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $352,946 - $423,595	1,051 New	1,051 $393,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.

Account

Wealthfront Advisers LLC Regeneron Pharmaceuticals, Inc. Transaction History